Papers by Keyword: Bone Filler

Abstract: Calcium sulfate dihydrate (CSD) cement has been used as bone filler for decades. It is also used as antibiotics carrier to treat osteomyelitis. However, CSD cement alone when applied at bone defect has some limitation such as its brittleness. The brittleness limits its handling property. Thus, the aim of this study is to fabricate granular CSD cement-gelatin (CSD-Gel) that has good handling property to be used as bone void filler. To prepare CSD-Gel composite, granular CSD was prepared from calcium sulfate hemihydrate (CaSO₄.0.5H₂O; CSH) and distilled water with water/powder (W/P) ratio of 0.5. The CSD cement was crushed and sieved into 300-500 μm. The obtained granular CSD was then mixed with 3 wt.% and 7 wt.% gelatin solution, followed by freeze drying for 48 hours. The CSD granules were surrounded by gelatin matrix in all specimens. It was observed that more gelatin matrix found in the space between the granules in in the composite with 7 wt% gelatin compared with that in 3 wt% gelatin. Mechanical evaluation revealed that CSD-Gel 7% has significant higher compressive strength compared with that of CSD-Gel 3%.

Abstract: Calcium sulfate dihydrate (CSD) cement has been used as bone void filler and antibiotic carrier for many years. However, the main drawback of CSD cement is its brittleness that limits its handling property. Thus, the aim of this study is to fabricate granular CSD cement-gelatin-polycaprolactone (CSD-Gel-PCL) to improve handling property. To prepare CSD-Gel-PCL composite, granular CSD was prepared from calcium sulfate hemihydrate (CaSO₄.0.5H₂O; CSH) and distilled water with water/powder (W/P) ratio of 0.5. The CSD cement was crushed and sieved into 300-500 μm. The obtained granular CSD was then mixed with 3 wt.%, 5 wt.% and 7 wt.% gelatin solution which previously mixed with PCL (50 wt% PCL, 50 wt% gelatin), followed by freeze drying for 48 hours. The CSD granules were able to bind together after the addition of gelatin and PCL matrix. After freeze drying, the CSD granules were not easy to remove from the composite body. Scanning electron microscopy (SEM) analysis revealed that CSD granules were surrounded by polymer matrix in all 3 different specimens in which the higher gelatin concentration, the more the matrix found between the granules. Mechanical evaluation suggested that all of the specimens showed the same stress-strain curve pattern. The CSD-Gel-PCL composite with 7 wt% gelatin has the highest strength compared with the other specimens. Stress-strain curves indicated that combination of CSD granules, gelatin and PCL has produced bone filler with improved handling property.

Abstract: Based on data from Indonesian Health Ministry in 2009, osteoporosis case reached 19,7 % of the populations in Indonesia, especially women in menopause period. The treatment was performed by consuming bisphosphonate drugs per oral which was not effective since the absorption intake of the drug was only less than 55% of the intake dosage. Because of that, the bone filler which also has a function as drug delivery system was developed. The hydroxyapatite-gelatin bone filler with the addition of alendronate was studied. To increase the characteristics of this bone filler, glutaraldehyde was introduced in the composite as a crosslinking agent. The concentration of 0.25%, 0.5%, and 0.75% were used. The bone filler was then characterized based on FTIR test, morphology test, compressive strength test, cytotoxicity test, and degradation test. The FTIR result showed that there was no significant difference between the sample with and without glutaraldehyde since the crosslinking bond of glutaraldehyde and gelatin was C=N bond which also presented in the gelatin. The morphology of the samples depicted a bigger pore size for higher glutaraldehyde concentration which also supported by lower compressive strength. All the samples were non-toxic based on the cytotoxicity test which had cell viability more than 100%. The degradation tests showed that with the presence of glutaraldehyde in the bone filler could maintain its form longer than the bone filler without glutaraldehyde. In conclusion, the presence of glutaraldehyde could increase the characteristics of the hydroxyapatite-gelatin composite with the addition of alendronate as a bone filler candidate for osteoporotic bone.

Abstract: We have previously developed a novel chelate-setting β-tricalcium phosphate (β-TCP) cement with non-fragmentation property in vivo. This novel cement has been set on the basis of chelate-setting mechanism of inositol phosphate (IP6). In this study, β-TCP powders were synthesized by mechanochemical method, and the as-prepared powders were heated at 600-1300°C for 1 h. Some properties of the resulting powders were examined. The crystalline phase of the resulting powders in the range of 600-1100°C was of β-TCP single phase. In the cases at 1200°C and 1300°C, the resulting powders were composed of β-TCP and α-TCP. Median particle sizes of the resulting powders increased with heating temperature from 5.35 μm up to 47.7 μm. Dissolution rate of Ca²⁺ ions from the β-TCP powders was measured by Japanese Industrial Standard T 0330-3. When the heating temperature was at 700°C, the Ca²⁺ ions solubility was highest among examined ones. The β-TCP powder heated at 700°C for 1 h will be expected as the starting powder for paste-like artificial bone filler with excellent bioresorbability.

Abstract: Macroporous nanostructured calcium phosphate scaffold was produced at low temperature using freeze casting technique. Aqueous suspension of tetracalcium phosphate and dicalcium phosphate anhydrous was freeze-casted into cylindrical samples using an automated freeze casting device and subsequently freeze-dried. The sample was stored at 37 °C and 100% relative humidity for 24h, and then kept in simulated body fluid (SBF) for 7 days. The phase composition and microstructure of scaffold was characterized by X-ray diffraction and scanning electronic microscopy, respectively. Cell proliferation and attachment was also studied using Rat calvarium osteoblasts. The results showed a porous structure with total porosity of 75% and pore diameter ranging 50-150 μm and compressive strength of 5 ± 1 Mpa. The scaffolds had been composed of needle-like nanocrystals at the range of 40-100 nm. The XRD and FTIR data confirmed complete conversion of tetracalcium phosphate and dicalcium phosphate reactants into carbonate-substituted apatite phase due to the immersion process without any other impure phases. The results of cell studies revealed well attachment of osteoblasts on the pores and walls of the scaffolds as well as a time dependent proliferation and increased alkaline phosphatase activity. The produced scaffold has the requirements of an osteoinductive material but more in vitro and in vivo studies are required to prove this suggestion.

Abstract: Calcium sulfate/tri-calcium phosphate (CaSO₄/TCP) composite bone fillers were fabricated through molding method. Their structure and properties were characterized by infrared spectroscope, scanning electronic spectroscope, x-ray diffraction and degradation test. The results show that TCP crystals were attached to the CaSO₄ crystals and prevented the growing of sulfate crystals. So their size is shorter than that of CaSO₄ crystals prepared from pure CaSO₄ semihydrate, and some even had defect. The resorption rate of CaSO₄ bone fillers was decreased when TCP was incorporated.

Abstract: Calcium sulfate/hydroxyapatie (CaSO4/HA) composite bone fillers were fabricated through molding method. Their structure and properties were characterized by infrared spectroscope, scanning electronic spectroscope, x-ray diffraction and degradation test. The results show that HA crystals were attached to the CaSO4 crystals and prevented the growing of sulfate crystals. So their size is shorter than that of CaSO4 crystals prepared from pure CaSO4 semihydrate, and some even had defect. The resorption rate of CaSO4 bone fillers was decreased when HA was incorporated.

Abstract: Plaster of Pairs is a common used implanting material. However, its rapid degradation or drug releasing rate as a bone filler or drug carrier does not meet the requirement of clinic application. In this paper, plaster of Pairs bone fillers loaded with drug was prepared and their degradation and the drug release period were adjusted by coating their surface with polymers. The results show that the structure of coatings can effectively control the degradation period of the bone fillers, and consequently the drug release rate.

Abstract: Nanocrystalline carbonated hydroxyapatite was produced through hydraulic conversion of calcium phosphate cement in simulated body fluid (SBF) and then heated in a microwave oven at 1000-1250 °C. The phase composition and microstructures were evaluated, before and after the thermal processing, using XRD and SEM, respectively. Total porosity and bending strength of the samples were also tested. Proliferation and morphology of osteoblastic cells on samples were evaluated using MTT method. Limited growth of apatite crystals was observed by the thermal treatment in which the samples exhibited a crystal size of ~ 150 nm at heating temperature of 1250 º. Based on the results, the microwave irradiation led to a little change in phase composition of carbonated apatite and slight amount of β-TCP phase was found together with large amount of apatite. The sample irradiated at 1250 °C formed more dense material having bending strength value up to 130 % that of unheated sample. The in vitro cell studies showed that the microwave irradiated samples could provide adequate cell proliferation and attachment.

Abstract: Injectable hydroxyapatite/collagen nanocomposite (HAp/Col) artificial bone was prepared utilizing gelation of sodium alginate (Na-Alg). Mass ratio of the HAp/Col powder, with or without Ca adsorption treatment and Na-Alg (80-120, 300-400, 500-600 cP in viscosity at 10 g/dm³) was fixed at 90/10. Injectable HAp/Col was prepared by mixing the HAp/Col powder with Na-Alg solution at several powder (HAp/Col)/liquid (Na-Alg solution) ratios (P/L ratio, g/cm³). The result of consistency measurement suggested that the operability of injectable HAp/Col paste could be controlled by both the P/L ratio and the viscosity of Na-Alg solution. According to the consistency measurement and practical feelings during mixing, P/L=1/1.67 (80-120 cP) and 1/1.89 (300-400, 500-600 cP) were considered to be the highest P/L ratio allowed to mix the HAp/Col paste with a spatula. At the P/L=1/2.33 (80-120 cP), the paste prepared with the non-treated HAp/Col powder, placed in an incubator (37 °C,relative humidity 100%) for 24h, demonstrated gel-like property, while the paste prepared with Ca-treated HAp/Col powder did putty-like property. The difference in their property might be caused by the initial bonding behavior between Alg and Ca²⁺ after mixing. The setting time measurement with Gillmore needle was impossible because they were toosoft for this method. Even though, their operability and coalescence/settingproperty could be used as the injectable bone filler.